Author response for "Baseline CD22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment"

crossref(2022)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要